LINDSEY GRADY: Open Payments
NPI 1689954828 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$19,235 in 206 payments from 17 companies in 2025. Trend: 2023 $11,878 · 2024 $4,698 · 2025 $19,235
Speaker / faculty: $11,800Travel & lodging: $3,885Food & beverage: $3,450Education: $100
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 36 | $16,276 |
| ABBVIE INC. | 39 | $475 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 22 | $460 |
| UCB, Inc. | 14 | $341 |
| Janssen Biotech, Inc. | 15 | $308 |
| Lilly USA, LLC | 10 | $291 |
| Galderma Laboratories, L.P. | 10 | $279 |
| E.R. Squibb & Sons, L.L.C. | 18 | $143 |
| Incyte Corporation | 4 | $116 |
| MAYNE PHARMA COMMERCIAL LLC | 12 | $116 |
Products named: OTEZLA, ILUMYA, Bimzelx, TREMFYA, SKYRIZI, NEMLUVIO, EBGLYSS, RINVOQ.
Industry payments across IN — which companies pay providers there.
